The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     
 

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Keating, S. M.
Right arrow Articles by Hill, A. V. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Keating, S. M.
Right arrow Articles by Hill, A. V. S.
The Journal of Immunology, 2005, 175: 5675-5680.
Copyright © 2005 by The American Association of Immunologists

Durable Human Memory T Cells Quantifiable by Cultured Enzyme-Linked Immunospot Assays Are Induced by Heterologous Prime Boost Immunization and Correlate with Protection against Malaria1

Sheila M. Keating*, Philip Bejon*, Tamara Berthoud*, Jenni M. Vuola2,*, Stephen Todryk*, Daniel P. Webster*, Susanna J. Dunachie*, Vasee S. Moorthy*, Samuel J. McConkey*, Sarah C. Gilbert{dagger} and Adrian V. S. Hill3,*,{dagger}

* Centre for Clinical Vaccinology and Tropical Medicine, Nuffield Department of Medicine, Churchill Hospital, and {dagger} Wellcome Trust Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom

Immunological memory is a required component of protective antimalarial responses raised by T cell-inducing vaccines. The magnitude of ex vivo IFN-{gamma} T cell responses is widely used to identify immunogenic vaccines although this response usually wanes and may disappear within weeks. However, protection in the field is likely to depend on durable central memory T cells that are not detected by this assay. To identify longer-lived memory T cells, PBMC from malaria-naive vaccinated volunteers who had received prime boost vaccinations with a combination of DNA and/or viral vectors encoding the multiepitope string-thrombospondin-related adhesion protein Ag were cultured in vitro with Ag for 10 days before the ELISPOT assay. Ex vivo T cell responses peaked at 7 days after the final immunization and declined substantially over 6 mo, but responses identified after T cell culture increased over the 6-mo period after the final immunization. Moreover, individual cultured ELISPOT responses at the day of challenge time point correlated significantly with degree of protection against malaria sporozoite challenge, whereas ex vivo responses did not, despite a correlation between the peak ex vivo response and magnitude of memory responses 6 mo later. This cultured assay identifies long-lasting protective T cell responses and therefore offers an attractive option for assessments of vaccine immunogenicity.




This article has been cited by other articles:


Home page
 CVIHome page
H. M. Vordermeier, G. S. Dean, I. Rosenkrands, E. M. Agger, P. Andersen, D. A. Kaveh, R. G. Hewinson, and P. J. Hogarth
Adjuvants Induce Distinct Immunological Phenotypes in a Bovine Tuberculosis Vaccine Model
Clin. Vaccine Immunol., October 1, 2009; 16(10): 1443 - 1448.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
H. M. Vordermeier, B. Villarreal-Ramos, P. J. Cockle, M. McAulay, S. G. Rhodes, T. Thacker, S. C. Gilbert, H. McShane, A. V. S. Hill, Z. Xing, et al.
Viral Booster Vaccines Improve Mycobacterium bovis BCG-Induced Protection against Bovine Tuberculosis
Infect. Immun., August 1, 2009; 77(8): 3364 - 3373.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
C. L. Trimble, S. Peng, F. Kos, P. Gravitt, R. Viscidi, E. Sugar, D. Pardoll, and T.C. Wu
A Phase I Trial of a Human Papillomavirus DNA Vaccine for HPV16+ Cervical Intraepithelial Neoplasia 2/3
Clin. Cancer Res., January 1, 2009; 15(1): 361 - 367.
[Abstract] [Full Text] [PDF]

Home page
 CVIHome page
X. Wang, A.-B. Moscicki, L. Tsang, A. Brockman, and M. Nakagawa
Memory T Cells Specific for Novel Human Papillomavirus Type 16 (HPV16) E6 Epitopes in Women Whose HPV16 Infection Has Become Undetectable
Clin. Vaccine Immunol., June 1, 2008; 15(6): 937 - 945.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
S. A. Calarota, A. Foli, R. Maserati, F. Baldanti, S. Paolucci, M. A. Young, C. M. Tsoukas, J. Lisziewicz, and F. Lori
HIV-1-Specific T Cell Precursors with High Proliferative Capacity Correlate with Low Viremia and High CD4 Counts in Untreated Individuals
J. Immunol., May 1, 2008; 180(9): 5907 - 5915.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
M. C. Huaman, L. B. Martin, E. Malkin, D. L. Narum, L. H. Miller, S. Mahanty, and C. A. Long
Ex Vivo Cytokine and Memory T Cell Responses to the 42-kDa Fragment of Plasmodium falciparum Merozoite Surface Protein-1 in Vaccinated Volunteers
J. Immunol., February 1, 2008; 180(3): 1451 - 1461.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
C. L. Hutchings, A. J. Birkett, A. C. Moore, and A. V. S. Hill
Combination of Protein and Viral Vaccines Induces Potent Cellular and Humoral Immune Responses and Enhanced Protection from Murine Malaria Challenge
Infect. Immun., December 1, 2007; 75(12): 5819 - 5826.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
P. Bejon, J. Mwacharo, O. Kai, S. Todryk, S. Keating, B. Lowe, T. Lang, T. W. Mwangi, S. C. Gilbert, N. Peshu, et al.
The Induction and Persistence of T Cell IFN-{gamma} Responses after Vaccination or Natural Exposure Is Suppressed by Plasmodium falciparum
J. Immunol., September 15, 2007; 179(6): 4193 - 4201.
[Abstract] [Full Text] [PDF]

Home page
 CVIHome page
J. G. Smith, H. R. Joseph, T. Green, J. A. Field, M. Wooters, R. M. Kaufhold, J. Antonello, and M. J. Caulfield
Establishing Acceptance Criteria for Cell-Mediated-Immunity Assays Using Frozen Peripheral Blood Mononuclear Cells Stored under Optimal and Suboptimal Conditions
Clin. Vaccine Immunol., May 1, 2007; 14(5): 527 - 537.
[Abstract] [Full Text] [PDF]

Home page
 CVIHome page
K. H. Kim, W. Greenfield, E. Shotts, and M. Nakagawa
Detection of Human Papillomavirus Type 16-Specific T Lymphocytes by a Recombinant Vaccinia Virus-Based Enzyme-Linked Immunospot Assay
Clin. Vaccine Immunol., April 1, 2007; 14(4): 362 - 368.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
P. Bejon, S. Keating, J. Mwacharo, O. K. Kai, S. Dunachie, M. Walther, T. Berthoud, T. Lang, J. Epstein, D. Carucci, et al.
Early Gamma Interferon and Interleukin-2 Responses to Vaccination Predict the Late Resting Memory in Malaria-Naive and Malaria-Exposed Individuals
Infect. Immun., November 1, 2006; 74(11): 6331 - 6338.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
S. J. Dunachie, M. Walther, J. E. Epstein, S. Keating, T. Berthoud, L. Andrews, R. F. Andersen, P. Bejon, N. Goonetilleke, I. Poulton, et al.
A DNA Prime-Modified Vaccinia Virus Ankara Boost Vaccine Encoding Thrombospondin-Related Adhesion Protein but Not Circumsporozoite Protein Partially Protects Healthy Malaria-Naive Adults against Plasmodium falciparum Sporozoite Challenge.
Infect. Immun., October 1, 2006; 74(10): 5933 - 5942.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
N. Goonetilleke, S. Moore, L. Dally, N. Winstone, I. Cebere, A. Mahmoud, S. Pinheiro, G. Gillespie, D. Brown, V. Loach, et al.
Induction of Multifunctional Human Immunodeficiency Virus Type 1 (HIV-1)-Specific T Cells Capable of Proliferation in Healthy Subjects by Using a Prime-Boost Regimen of DNA- and Modified Vaccinia Virus Ankara-Vectored Vaccines Expressing HIV-1 Gag Coupled to CD8+ T-Cell Epitopes.
J. Virol., May 1, 2006; 80(10): 4717 - 4728.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2005 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2005 by The American Association of Immunologists, Inc. All rights reserved.